(Total Views: 357)
Posted On: 02/15/2018 1:37:36 AM
Post# of 72436
![Avatar](https://investorshangout.com/images/ProfileImages/398685088_3064_306524.png)
Tetraphase’s antibiotic eravacycline, B’s potential competitor, failed Phase 3 and stock dropped 60%.
https://www.fiercebiotech.com/biotech/tetraph...ase-3-flop
https://www.fiercebiotech.com/biotech/tetraph...ase-3-flop
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)